Universal Screening For MRSA Does Not Reduce Infections – JAMA Study
This article was originally published in The Gray Sheet
Executive Summary
Using a rapid molecular assay to screen all surgical patients on admission for a prevalent drug-resistant infection did not reduce the incidence of hospital-acquired infections in a Swiss study involving more than 20,000 patients